Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
The HEART BREAK Study: Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
1 other identifier
interventional
228
0 countries
N/A
Brief Summary
Purpose
- 1.To investigate the effects of cardiac imaging radiation on the induction of DNA double-strand breaks by enumerating gamma-H2AX foci in blood lymphocytes and plucked hair follicle cells.
- 2.To estimate whether the use of breast shields in cardiac computed tomographic angiography (CCTA) limits the effective radiation exposure of breast tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable coronary-artery-disease
Started Mar 2011
Typical duration for not_applicable coronary-artery-disease
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 19, 2015
CompletedFirst Posted
Study publicly available on registry
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedResults Posted
Study results publicly available
January 19, 2017
CompletedJuly 11, 2017
June 1, 2017
4.5 years
November 19, 2015
November 18, 2016
June 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging
The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.
Change from baseline double strand DNA breaks at 30 minutes post-imaging
Study Arms (3)
CCTA Breast Shields
ACTIVE COMPARATORWithin female subset, randomization to wearing bismuth breast shield.
CCTA No Breast Shields
NO INTERVENTIONWithin female subset, randomization to wearing no bismuth breast shield (standard of care).
Observational Arm
NO INTERVENTIONNon-females undergoing CTA and subjects undergoing cardiac catheterization and nuclear medicine testing.
Interventions
Breast shield placement (randomized) among women.
Eligibility Criteria
You may qualify if:
- Adult male and female adult subjects (age greater than 18 years)
- Referred for cardiac computed tomography angiography (CCTA), myocardial perfusion scintigraphy (MPS), or diagnostic invasive coronary angiography (ICA).
You may not qualify if:
- Female patients that identify themselves as pregnant or have a positive pregnancy test prior to cardiac imaging.
- History (present or past) of leukemia or lymphoma.
- History of radiation therapy
- X-ray examination or scintigraphy within the last 72 hours.
- History of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
- Patients undergoing percutaneous coronary intervention at completion of diagnostic left heart catheterization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Participants were enrolled at one center and using one CT scanner, variable shield types and shield sizes were not studied, and further work is needed to examine tissue-specific responses to radiation and shielding.
Results Point of Contact
- Title
- Michael K. Cheezum, MD
- Organization
- Ft. Belvoir Community Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Todd C Villines, MD
WRNMMC
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Cardiovascular Research
Study Record Dates
First Submitted
November 19, 2015
First Posted
December 1, 2015
Study Start
March 1, 2011
Primary Completion
September 1, 2015
Study Completion
December 1, 2015
Last Updated
July 11, 2017
Results First Posted
January 19, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share